Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 iito 650x76px

News > All

Total search results: 12048 | Ordered by Date (descending)
1 2 3 ... 119 120 121  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Puma Biotechnology, Inc.. (12/2/19). "Press Release: Puma Biotechnology Amends License Agreement with Pierre Fabre to Include Additional Countries". Berlin. 2019-12-02
Owkin. (12/2/19). "Press Release: Owkin Teams up with NVIDIA and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York. 2019-12-02
Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. 2019-12-02
Sensorion S.A.. (12/2/19). "Press Release: Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy". Montpellier. 2019-12-02
Audentes Therapeutics, Inc.. (12/2/19). "Press Release: Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics". Tokyo & San Francisco, CA. 2019-12-02
Diabeloop S.A.. (12/2/19). "Press Release: Diabeloop Completes Record-breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions". Grenoble. 2019-12-02
Ligand Pharmaceuticals Inc.. (12/2/19). "Press Release: Ligand Enters into Worldwide OmniAb Platform License Agreement with Sanofi". San Diego, CA. 2019-12-02
MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier. 2019-11-28
Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. 2019-11-27
MaxiVax S.A.. (11/26/19). "Press Release: MaxiVax Awarded €2,785,000 European Commission Grant and Announces Successful Closing of Its Series B 2 Round for an Amount of CHF 5 Million". Geneva. 2019-11-26
Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. 2019-11-26
Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. 2019-11-26
Lonza Group Ltd.. (11/26/19). "Press Release: Lonza and Dinaqor Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies". Basel & Pfäffikon. 2019-11-26
Sangamo Therapeutics, Inc.. (11/26/19). "Press Release: Sangamo Therapeutics Appoints James R. Meyers to Its Board of Directors". Brisbane, CA. 2019-11-26
Alkermes plc. (11/25/19). "Press Release: Alkermes Completes Acquisition of Rodin Therapeutics". Dublin. 2019-11-25
Asahi Kasei Corporation. (11/25/19). "Press Release: Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc. to Accelerate Transformation into a Global Health Care Company". Tokyo. 2019-11-25
Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo. 2019-11-25
Alexandria Real Estate Equities, Inc.. (11/25/19). "Press Release: Alexandria Real Estate Equities, Inc. Partners With World-Class Life Science Consortium in Greater Boston". Pasadena, CA. 2019-11-25
Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA. 2019-11-25
Veloxis Pharmaceuticals A/S. (11/25/19). "Press Release: Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis [Not for any jurisdiction where violation of law]". Copenhagen. 2019-11-25
Roche. (11/25/19). "Press Release: FDA Grants Priority Review to Roche’s Risdiplam for Spinal Muscular Atrophy". Basel. 2019-11-25
ChemoCentryx Inc.. (11/25/19). "Press Release: ChemoCentryx and VFMCRP Announce Positive Topline Data from Pivotal Phase III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA-Associated Vasculitis". Mountain View, CA & St. 2019-11-25
Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel. 2019-11-24
Roche. (11/22/19). "Press Release: Roche Presents Pivotal Data Demonstrating Tecentriq in Combination with Avastin Improves Overall Survival in People with the Most Common Form of Liver Cancer". Basel. 2019-11-22
Immunitas Therapeutics Inc.. (11/21/19). "Press Release: Immunitas Therapeutics Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform". Boston, MA. 2019-11-21
Tissium. (11/20/19). "Press Release: Tissium Closes €39M Series B Funding Round". Paris. 2019-11-20
Sophia Genetics S.A.. (11/20/19). "Press Release: Sophia Genetics Welcomes Milton Silva-Craig to Its Board of Directors". Boston, MA & Lausanne. 2019-11-20
CRISPR Therapeutics AG. (11/20/19). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. 2019-11-20
Werewolf Therapeutics, Inc.. (11/20/19). "Press Release: Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicines". Cambridge, MA. 2019-11-20
Qiagen N.V.. (11/20/19). "Press Release: Qiagen and LabCorp Deepen Relationship with Widespread Use of Bioinformatics Solutions". Hilden & Germantown, MD. 2019-11-20
Coulter Partners. (11/20/19). "Press Release: Coulter Partners Opens Brussels Office and Makes Six Strategic Appointments". 2019-11-20
MorphoSys AG. (11/20/19). "Press Release: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure". Planegg. 2019-11-20
CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. 2019-11-19
Sangamo Therapeutics, Inc.. (11/19/19). "Press Release: Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation". Brisbane, CA. 2019-11-19
Novo Holdings A/S. (11/19/19). "Press Release: Novo Ventures and Broad Institute of MIT and Harvard Launch Drug Discovery »Greenhouse« to Drive Creation of Innovative New Therapies". Boston, MA. 2019-11-19
CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for Severe Hemoglobinopathies". Zug 2019-11-19
Novo Nordisk A/S. (11/18/19). "Press Release: Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-related Cardio-metabolic Diseases". Lexington, MA & Bagsvaerd. 2019-11-18
Rodin Therapeutics Inc.. (11/18/19). "Press Release: Alkermes to Acquire Rodin Therapeutics". Dublin & Boston, MA. 2019-11-18
Rentschler Biopharma SE. (11/18/19). "Press Release: Rentschler Biopharma Appoints New Executives to Join U.S. Team". Laupheim & Milford, MA. 2019-11-18
Qiagen N.V.. (11/15/19). "Press Release: Qiagen Receives Several Conditional, Non-binding Indications of Interest, Enters into Discussions to Explore Potential Strategic Alternatives". Venlo. 2019-11-15
Okra Technologies Ltd.. (11/15/19). "Press Release: Okra Becomes a Veeva Technology Partner". Cambridge. 2019-11-15
MorphoSys AG. (11/15/19). "Press Release: MorphoSys Continues to Build Commercial Presence by Opening New U.S. Headoffice". Planegg & Boston, MA. 2019-11-15
Fujifilm Diosynth Biotechnologies U.S.A. Inc.. (11/14/19). "Press Release: Fujifilm Diosynth Biotechnologies Announces $55 Millionn USD Investment to Expand Gene Therapy Development Capabilities". College Station, TX. 2019-11-14
Fujifilm Corporation. (11/14/19). "Press Release: Fujifilm Announces Expansion of its Biopharmaceutical Contract Development and Manufacturing Business". Tokyo. 2019-11-14
Innate Pharma S.A.. (11/13/19). "Press Release: Innate Pharma Third Quarter 2019 Report". 2019-11-13
Editas Medicine, Inc.. (11/12/19). "Press Release: Editas Medicine Announces Third Quarter 2019 Results and Update". Cambridge, MA. 2019-11-12
Editas Medicine, Inc.. (11/12/19). "Press Release: Editas Medicine and Celgene Corporation Amend Existing Collaboration to Develop and Commercialize Autologous and Allogeneic T Cell Medicines for the Treatment of Cancer and Autoimmune Diseases". Cambridg 2019-11-12
Kiadis Pharma N.V.. (11/12/19). "Press Release: Kiadis Pharma Changes Strategy to Focus Solely on Development of Natural Killer (NK) Cell Therapeutics and Terminates Development of ATIR101". Amsterdam. 2019-11-12
Genedata AG. (11/12/19). "Press Release: Immatics Implements Genedata Biologics into Proprietary T-Cell Receptor Discovery and Engineering XCEPTOR Platform". Basel. 2019-11-12
Bluebird Bio, Inc.. (11/12/19). "Press Release: Bluebird Bio and Forty Seven Announce a Research Collaboration to Study an All Antibody Conditioning Regimen for Use in Combination with Autologous Lentiviral Vector Hematopoietic Stem Cell Gene Therapy". C 2019-11-12
[iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. 2019-11-11
Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge. 2019-11-11
Invitae Corporation. (11/11/19). "Press Release: Invitae to Acquire Clear Genetics". San Francisco, CA. 2019-11-11
Argenx SE. (11/8/19). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. 2019-11-08
Centogene B.V.. (11/7/19). "Press Release: Centogene Announces Pricing of Initial Public Offering". Cambridge, MA & Rostock. 2019-11-07
Teva Pharmaceutical Industries Ltd.. (11/7/19). "Press Release: Teva Announces Appointment of New Chief Financial Officer". Jerusalem. 2019-11-07
Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge. 2019-11-07
Waters Corporation. (11/7/19). "Press Release: World’s First Cyclic IMS Mass Spectrometer Installed at Aston University". Milford, MA. 2019-11-07
Argenx SE. (11/7/19). "Press Release: Argenx Raises $484 Million in Gross Proceeds in a Global Offering". Breda & Ghent. 2019-11-07
eGenesis Inc.. (11/7/19). "Press Release: eGenesis Announces $100 Million Series B Financing". Cambridge, MA. 2019-11-07
Mission Bio, Inc.. (11/6/19). "Press Release: Mission Bio Launches Industry-first Single-cell Multi-omics Capabilities to Simultaneously Detect DNA and Protein from the Same Cell". South San Francisco, CA. 2019-11-06
Argenx SE. (11/6/19). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. 2019-11-06
Artios Pharma Ltd.. (11/6/19). "Press Release: Artios Pharma, MD Anderson and ShangPharma Announce In-licensing Agreement for DNA Damage Response Inhibitor". Cambridge, New York, NY, Houston, TX & South San Franicsco, CA. 2019-11-06
Rentschler Biopharma SE. (11/6/19). "Press Release: Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub". Laupheim & Milford, MA. 2019-11-06
Ervaxx Ltd.. (11/6/19). "Press Release: Ervaxx Launches to Pioneer the Use of Dark Antigens for the Development of Off-the-Shelf Cancer Vaccines and T-cell Receptor-based Immunotherapies". London. 2019-11-06
AstraZeneca plc. (11/6/19). "Press Release: AstraZeneca Announces Three Large-scale Initiatives in China to Advance Global Medicine Research and Development". 2019-11-06
Greenough. (11/6/19). "Press Release: Agencies Align Life Science/Healthcare Expertise to Offer Integrated Marketing Services on Both Sides of the Pond". Watertown, MA. 2019-11-06
SciRhom GmbH. (11/5/19). "Press Release: SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases". Munich. 2019-11-05
ADC Therapeutics S.A.. (11/5/19). "Press Release: ADC Therapeutics Appoints Jennifer Herron as Chief Commercial Officer". Lausanne. 2019-11-05
Santhera Pharmaceuticals AG. (11/4/19). "Press Release: Santhera Appoints New Chief Executive Officer". Pratteln. 2019-11-04
Pieris Pharmaceuticals, Inc.. (11/4/19). "Press Release: Pieris Pharmaceuticals Announces $32 Million Private Placement and Potential Funding Mechanism for PRS-060 Co-development Opt-in". Boston, MA. 2019-11-04
Fibit, Inc.. (11/1/19). "Press Release: Fitbit to Be Acquired by Google". San Francisco, CA. 2019-11-01
Sangamo Therapeutics, Inc.. (11/1/19). "Press Release: Sangamo Therapeutics Appoints Sung Lee as Executive Vice President and Chief Financial Officer". Brisbane, CA. 2019-11-01
Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel. 2019-10-31
Mesa Laboratories, Inc.. (10/31/19). "Press Release: Mesa Labs Acquires Gyros Protein Technologies". Lakewood, CO. 2019-10-31
Bluebird Bio, Inc.. (10/31/19). "Press Release: Bluebird Bio Reports Third Quarter 2019 Financial Results and Highlights Operational Progress". Cambridge, MA. 2019-10-31
Bicycle Therapeutics plc. (10/31/19). "Press Release: Bicycle Therapeutics Announces Appointment of Veronica Jordan, Ph.D., to Board of Directors". Cambridge & Boston, MA. 2019-10-31
BeiGene, Ltd.. (10/31/19). "Press Release: BeiGene Announces Global Strategic Oncology Collaboration with Amgen". Cambridge, MA & Beijing. 2019-10-31
Tmunity Therapeutics, Inc.. (10/31/19). "Press Release: Tmunity Raises $75 Million in Series B Financing to Advance Next-Generation T-Cell Therapies". Philadeliphia, PA. 2019-10-31
genOway S.A.. (10/30/19). "Press Release: The Institut Pasteur and Cellectis Extend Exclusive License Rights by Granting genOway the Authority to Take Action against Infringement". Lyon & Paris. 2019-10-30
CEM Corporation. (10/29/19). "Press Release: CEM Corporation Acquires Key Assets of Intavis Bioanalytical Instruments". Matthews, NC. 2019-10-29
Cellectis S.A.. (10/29/19). "Press Release: First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma". New York, NY. 2019-10-29
Disc Medicine. (10/29/19). "Press Release: Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production". Cambridge, MA. 2019-10-29
Bicycle Therapeutics plc. (10/29/19). "Press Release: Bicycle Therapeutics Announces Appointment of Nigel Crockett, Ph.D., as Chief Business Officer". Cambridge & Boston, MA. 2019-10-29
Disc Medicine. (10/29/19). "Press Release: Disc Medicine Expands Pipeline Focused on Hepcidin Pathway. Enters into Exclusive Agreement with AbbVie for Series of Hemojuvelin Antagonist Monoclonal Antibodies". Cambridge, MA. 2019-10-29
Phathom Pharmaceuticals, Inc.. (10/29/19). "Press Release: Phathom Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Buffalo Grove, IL. 2019-10-29
Boehringer Ingelheim. (10/29/19). "Press Release: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing". Ingelheim. 2019-10-29
TherapeuticsMD, Inc.. (10/29/19). "Press Release: TherapeuticsMD Announces Closing of Its Underwritten Public Offering of Common Stock". Boca Raton, FL. 2019-10-29
SP Industries, Inc.. (10/28/19). "Press Release: SP Acquires Spain Based i-Dositecno". Warminster, PA. 2019-10-28
Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. 2019-10-28
Parc Cientific de Barcelona (BCP, Barcelona Science Park Foundation). (10/28/19). "Press Release: Molomics Opens an Investment Round to Accelerate an Innovative Project against Parkinson’s". Planegg & Mechelen. 2019-10-28
OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD. 2019-10-28
CRISPR Therapeutics AG. (10/28/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results". Zug & Cambridge, MA. 2019-10-28
Cato Research, LLC. (10/28/19). "Press Release: Cato Research Announces Merger with SMS-Oncology". Durham, NC. 2019-10-28
Editas Medicine, Inc.. (10/28/19). "Press Release: Editas Medicine Appoints Judith R. Abrams, M.D., as Chief Medical Officer". Cambridge, MA. 2019-10-28
BiomX Ltd.. (10/28/19). "Press Release: Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.". New York, NY & Ness Ziona. 2019-10-28
PierianDx. (10/28/19). "Press Release: PierianDx Closes Series B Financing Round to Facilitate the Democratization of Clinical Next-Generation Sequencing". St. Louis, MO. 2019-10-28
Uniqure N.V.. (10/28/19). "Press Release: Uniqure Announces Third Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. 2019-10-28
Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock. 2019-10-28
Galapagos N.V.. (10/25/19). "Press Release: Galapagos Receives Transparency Notification from Wellington Management Group LLP". Mechelen. 2019-10-25
1 2 3 ... 119 120 121  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 iito 650x76px

» top